Added to YB: 2021-09-23
Pitch date: 2021-09-23
NXTC:US [bullish]
NextCure, Inc.
-86.45%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer.
Market Cap
$10.9M
Pitch Price
$82.20
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.97
P/E
-0.20
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
NextCure, Inc. NXTC:US
A summary for this pitch has not been created yet.
Read full article (0 min)